genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Drug Discovery
First-In-Human Trial of Marburg Vaccine Shows Promising Results
Infectious Disease Diagnostics
Exploring Ways to Block Malaria Transmission
Infectious Diseases
Collective Measles Virus Mutations Linked to Fatal Encephalitis
Bioprocessing
Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility
Infectious Diseases
Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Children
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Blood Disorders
Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds
Artificial Intelligence
Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block
Antibodies
Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis
Bioprocessing
Cell and Gene Therapy Scale-Up Challenges
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Companies
Biogen
Biogen
23andMe
Abbvie
AdnaGen
Agilent Technologies
Alexion Pharmaceuticals
Amgen
Astellas
AstraZeneca
Audentes Therapeutics
Berkeley Lights
Bio-Rad Laboratories
Biogen
Cancer Genetics
Catalent
Charles RIver Laboratories
Dana-Farber Cancer Institute
deCODE genetics
Dicerna
Dimension Therapeutics
Exact Sciences
Foundation Medicine
GE Healthcare
GeneInsight
Gilead Sciences
GlaxoSmithKline
Halozyme Therapeutics
Hitachi High-Technologies
Horizon Discovery Group
Human Longevity
Illumina
Jackson Laboratory
Janssen Biotech
LabCorp
Maravai LifeSciences
MD Anderson
MDxHealth
MedImmune
Memorial Sloan Kettering Cancer Center
Merck & Co
Merck KGaA
NanoString Technologies
Novartis
Pathology
PerkinElmer
PersonalizeDx
Qiagen
RayBiotech
Roche
Sanofi
shire
Sigma-Aldrich
Synthego
Takeda
Thermo Fisher Scientific
UCB Biosciences
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Biogen
“Some Hope”: Biogen, Eisai Release Positive Phase II Results for Alzheimer’s Candidate
Biogen
Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success
Biogen
BMS Licenses mAb and Fusion Protein Drugs to Biogen and to Roche for up to $1B
Biogen
Biogen Raising Minority Stake in Samsung Bioepis in $672M Deal
Biogen
Biogen Mulls Tofersen’s Future after Drug Misses Phase III Trial’s Primary Endpoint in ALS
Biogen
Biogen Acquires Stroke Candidate Cirara from Remedy for $120M Upfront
Drug Discovery
Biogen Poised for Pipeline Growth, Samsung Eyes New Drug Expansion after...
Biogen
Biogen Pays Ionis $10M as Phase I/IIa Trial Launched for Alzheimer’s...
Biogen
Biogen Replenishes Eye Disease Gene Therapy Pipeline with Planned $877M Nightstar...
Financing
StockWatch: Biogen Stays Flat Despite Positive 128-Week Aduhelm Data
Biogen
AbbVie Launches, Biogen Tweaks Alzheimer’s Collaborations
Biogen
Fujifilm Diosynth to Expand with $890M Purchase of Biogen’s Danish Biologics...
Genome Editing
Scribe Pursues CRISPR Therapies with Expanded Biogen Collaboration
Biogen
Biogen to Develop Alkermes’ MS Candidate ALKS 8700
Biogen
Biogen Shares Surge after Reversal on Alzheimer’s Candidate Aducanumab
1
2
3
Page 1 of 3
Scroll Up
Login
Subscribe